Assistant Professor, Department of Medicine, Faculty of Medicine, McGill University, Department of Medicine, Division of Hematology, MUHC
My research focuses on the second most common hematologic malignancy in adults, multiple myeloma. We focus on bench to bedside research with emphasis on both basic science and clinical trials in multiple myeloma. In the lab we are focusing on the impact of the microenvironment on the development and progression of multiple myeloma. We are looking at the role of the multiple myeloma cell in osteoblastic development and its impact on multiple myeloma bone disease. We are working on novel agents which target either the myeloma cell directly or its microenvironment with the aid of a novel transgenic model of multiple myeloma.
years treating myeloma:
Number of Myeloma Patients Treated Annually:
Details & contact info
Cedars Cancer Centre 1001 Decarie Boulevard
Montreal, Canada, Canada, H4A 3J1
Send a message to Michael Sebag, MD, PhD